Iluvatar CoreX: In 2025, the Company Secures RMB 1.034 Billion in Annual Revenue, Marking a 91.6% Year-on-Year Surge
7 hour ago / Read about 0 minute
Author:小编   

Iluvatar CoreX unveiled its inaugural 2025 performance report subsequent to its listing on the Hong Kong Stock Exchange. The report highlights that the company's annual revenue soared to RMB 1.034 billion, reflecting a significant 91.6% increase from the previous year. Moreover, its gross profit climbed to RMB 558 million, a remarkable 110.5% rise year-on-year. The fact that the gross profit growth rate outstripped that of revenue underscores a consistent enhancement in product profitability. Additionally, the adjusted net loss contracted by 32.1% compared to the previous year, accompanied by concurrent advancements in R&D and operational efficiency. This demonstrates a solid financial foundation and heralds high-caliber performance growth.